A Review of Collagen Cross-Linking in Cornea and Sclera

Riboflavin/UVA cross-linking is a technique introduced in the past decades for the treatment of keratoconus, keratectasia, and infectious keratitis. Its efficacy and safety have been investigated with clinical and laboratory studies since its first clinical application by Wollensak for the treatment...

Full description

Bibliographic Details
Main Authors: Zhang, Xiao, Tao, Xiang-chen, Zhang, Jian, Li, Zhi-wei, Xu, Yan-yun, Wang, Yu-meng, Zhang, Chun-xiao, Mu, Guo-ying
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398937/
id pubmed-4398937
recordtype oai_dc
spelling pubmed-43989372015-04-28 A Review of Collagen Cross-Linking in Cornea and Sclera Zhang, Xiao Tao, Xiang-chen Zhang, Jian Li, Zhi-wei Xu, Yan-yun Wang, Yu-meng Zhang, Chun-xiao Mu, Guo-ying Review Article Riboflavin/UVA cross-linking is a technique introduced in the past decades for the treatment of keratoconus, keratectasia, and infectious keratitis. Its efficacy and safety have been investigated with clinical and laboratory studies since its first clinical application by Wollensak for the treatment of keratoconus. Although its complications are encountered during clinical practice, such as infection inducing risk, minimal invasion merits a further investigation on its future application in clinical practice. Recently, collagen cross-linking in sclera shows a promising prospect. In present study, we summarized the representative studies describing the clinical and laboratory application of collagen cross-linking published in past decades and provided our opinion on the positive and negative results of cross-linking in the treatment of ophthalmic disorders. Hindawi Publishing Corporation 2015 2015-04-02 /pmc/articles/PMC4398937/ /pubmed/25922758 http://dx.doi.org/10.1155/2015/289467 Text en Copyright © 2015 Xiao Zhang et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Zhang, Xiao
Tao, Xiang-chen
Zhang, Jian
Li, Zhi-wei
Xu, Yan-yun
Wang, Yu-meng
Zhang, Chun-xiao
Mu, Guo-ying
spellingShingle Zhang, Xiao
Tao, Xiang-chen
Zhang, Jian
Li, Zhi-wei
Xu, Yan-yun
Wang, Yu-meng
Zhang, Chun-xiao
Mu, Guo-ying
A Review of Collagen Cross-Linking in Cornea and Sclera
author_facet Zhang, Xiao
Tao, Xiang-chen
Zhang, Jian
Li, Zhi-wei
Xu, Yan-yun
Wang, Yu-meng
Zhang, Chun-xiao
Mu, Guo-ying
author_sort Zhang, Xiao
title A Review of Collagen Cross-Linking in Cornea and Sclera
title_short A Review of Collagen Cross-Linking in Cornea and Sclera
title_full A Review of Collagen Cross-Linking in Cornea and Sclera
title_fullStr A Review of Collagen Cross-Linking in Cornea and Sclera
title_full_unstemmed A Review of Collagen Cross-Linking in Cornea and Sclera
title_sort review of collagen cross-linking in cornea and sclera
description Riboflavin/UVA cross-linking is a technique introduced in the past decades for the treatment of keratoconus, keratectasia, and infectious keratitis. Its efficacy and safety have been investigated with clinical and laboratory studies since its first clinical application by Wollensak for the treatment of keratoconus. Although its complications are encountered during clinical practice, such as infection inducing risk, minimal invasion merits a further investigation on its future application in clinical practice. Recently, collagen cross-linking in sclera shows a promising prospect. In present study, we summarized the representative studies describing the clinical and laboratory application of collagen cross-linking published in past decades and provided our opinion on the positive and negative results of cross-linking in the treatment of ophthalmic disorders.
publisher Hindawi Publishing Corporation
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398937/
_version_ 1613212237779959808